Clinical characteristics and follow-up of Korean patients with adrenal incidentalomas |
Cho, Yoon Young
(Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Suh, Sunghwan (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Joung, Ji Young (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Jeong, Hyemin (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Je, Dongmo (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Yoo, Hongseok (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Park, Taek Kyu (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Min, Yong-Ki (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Kim, Kwang-Won (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Kim, Jae Hyeon (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) |
1 | Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004;25:309-340. DOI ScienceOn |
2 | Bovio S, Cataldi A, Reimondo G, et al. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 2006;29:298- 302. DOI |
3 | Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med 2003;138:424-429. DOI ScienceOn |
4 | Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 2003;149:273-285. DOI ScienceOn |
5 | Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy: Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000;85:637-644. |
6 | Allolio B, Fassnacht M. Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 2006;91:2027-2037. DOI ScienceOn |
7 | Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 2005;366:665-675. DOI ScienceOn |
8 | Prinz RA, Brooks MH, Churchill R, et al. Incidental asymptomatic adrenal masses detected by computed tomographic scanning: is operation required? JAMA 1982;248:701-704. DOI ScienceOn |
9 | Geelhoed GW, Druy EM. Management of the adrenal "incidentaloma". Surgery 1982;92:866-874. |
10 | Ng VW, Ma RC, So WY, et al. Evaluation of functional and malignant adrenal incidentalomas. Arch Intern Med 2010;170:2017-2020. DOI ScienceOn |
11 | Jeong HS, Kim HJ, Kim HS, et al. Clinical characteristics for 132 patients with adrenal incidentaloma. J Korean Endocr Soc 2007;22:260-265. DOI ScienceOn |
12 | Murai M, Baba S, Nakashima J, Tachibana M. Management of incidentally discovered adrenal masses. World J Urol 1999;17:9-14. DOI |
13 | Kim HY, Kim SG, Lee KW, et al. Clinical study of adrenal incidentaloma in Korea. Korean J Intern Med 2005;20:303-309. DOI ScienceOn |
14 | Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocr Rev 1995;16:460-484. |
15 | Yeh HC. Sonography of the adrenal glands: normal glands and small masses. AJR Am J Roentgenol 1980;135:1167-1177. DOI |
16 | Abecassis M, McLoughlin MJ, Langer B, Kudlow JE. Serendipitous adrenal masses: prevalence, significance, and management. Am J Surg 1985;149:783-788. DOI ScienceOn |
17 | Barzon L, Scaroni C, Sonino N, et al. Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Endocrinol Metab 1998;83:55-62. |
18 | Flecchia D, Mazza E, Carlini M, et al. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour. Clin Endocrinol (Oxf ) 1995;42:129-134. DOI ScienceOn |
19 | Herrera MF, Grant CS, van Heerden JA, Sheedy PF, Ilstrup DM. Incidentally discovered adrenal tumors: an institutional perspective. Surgery 1991;110:1014-1021. |
20 | Barzon L, Fallo F, Sonino N, Boscaro M. Development of overt Cushing's syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 2002;146:61-66. DOI ScienceOn |
21 | Bulow B, Ahren B; Swedish Research Council Study Group of Endocrine Abdominal Tumours. Adrenal incidentaloma: experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med 2002;252:239-246. DOI ScienceOn |
22 | Kasperlik-Zeluska AA, Roslonowska E, Slowinska-Srzednicka J, et al. Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol (Oxf ) 1997;46:29-37. DOI ScienceOn |
23 | Russell RP, Masi AT, Richter ED. Adrenal cortical adenomas and hypertension: a clinical pathologic analysis of 690 cases with matched controls and a review of the literature. Medicine (Baltimore) 1972;51:211-225. DOI |
24 | Comlekci A, Yener S, Ertilav S, et al. Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. Endocrine 2010;37:40-46. DOI ScienceOn |
25 | Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M. Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 1999;84:520- 526. |
26 | Terzolo M, Bovio S, Pia A, et al. Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. Eur J Endocrinol 2005;153:307-315. DOI ScienceOn |
27 | Hamrahian AH, Ioachimescu AG, Remer EM, et al. Clinical utility of noncontrast computed tomography attenuation value (hounsf ield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience. J Clin Endocrinol Metab 2005;90:871-877. DOI |
28 | Korobkin M, Brodeur FJ, Yutzy GG, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol 1996;166:531- 536. DOI ScienceOn |
29 | Cirillo RL Jr, Bennett WF, Vitellas KM, Poulos AG, Bova JG. Pathology of the adrenal gland: imaging features. AJR Am J Roentgenol 1998;170:429-435. DOI ScienceOn |
30 | Tauchmanova L, Rossi R, Biondi B, et al. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 2002;87:4872-4878. DOI ScienceOn |
31 | Rossi R, Tauchmanova L, Luciano A, et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 2000;85:1440-1448. |
32 | Libe R, Dall'Asta C, Barbetta L, Baccarelli A, Beck-Peccoz P, Ambrosi B. Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol 2002;147:489-494. DOI ScienceOn |
33 | Song JH, Chaudhry FS, Mayo-Smith WW. The incidental indeterminate adrenal mass on CT (> 10 H) in patients without cancer: is further imaging necessary? Follow-up of 321 consecutive indeterminate adrenal masses. AJR Am J Roentgenol 2007;189:1119-1123. DOI |
34 | Young WF Jr. Clinical practice: the incidentally discovered adrenal mass. N Engl J Med 2007;356:601-610. DOI ScienceOn |
35 | Cawood TJ, Hunt PJ, O'Shea D, Cole D, Soule S. Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant: time for a rethink? Eur J Endocrinol 2009;161:513-527. DOI ScienceOn |